Terms: = Lung cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Diagnosis
25 results:
1. Construction and Validation of a lung cancer Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers.
Kang C; Wang D; Zhang X; Wang L; Wang F; Chen J
Comput Math Methods Med; 2021; 2021():9987067. PubMed ID: 34257703
[TBL] [Abstract] [Full Text] [Related]
2. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract] [Full Text] [Related]
3. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G
PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970
[TBL] [Abstract] [Full Text] [Related]
4. Quantitative assessment of the diagnostic role of fhit promoter methylation in non-small cell lung cancer.
Geng X; Pu W; Tan Y; Lu Z; Wang A; Tan L; Chen S; Guo S; Wang J; Chen X
Oncotarget; 2017 Jan; 8(4):6845-6856. PubMed ID: 28036263
[TBL] [Abstract] [Full Text] [Related]
5. Establishment of two data mining models of lung cancer screening based on three gene promoter methylations combined with telomere damage.
Wang W; Feng X; Duan X; Tan S; Wang S; Wang T; Feng F; Wu Y; Wu Y
Int J Biol Markers; 2017 Mar; 32(1):e141-e146. PubMed ID: 27716889
[TBL] [Abstract] [Full Text] [Related]
6. Application of artificial neural network model combined with four biomarkers in auxiliary diagnosis of lung cancer.
Duan X; Yang Y; Tan S; Wang S; Feng X; Cui L; Feng F; Yu S; Wang W; Wu Y
Med Biol Eng Comput; 2017 Aug; 55(8):1239-1248. PubMed ID: 27766520
[TBL] [Abstract] [Full Text] [Related]
7. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive fhit knockout mouse.
Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
[TBL] [Abstract] [Full Text] [Related]
8. Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients.
Huang T; Chen X; Hong Q; Deng Z; Ma H; Xin Y; Fang Y; Ye H; Wang R; Zhang C; Ye M; Duan S
Sci Rep; 2015 Mar; 5():8897. PubMed ID: 25754026
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of the prognostic value of methylation status and expression levels of fhit, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.
Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA
Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385
[TBL] [Abstract] [Full Text] [Related]
10. Detection of fhit and p16 mRNA deletion in biopsy specimens obtained by bronchoscopy for the diagnosis of lung cancer.
Chen P; Li J; Wang Y; Zhu LR; Hu YM; Tong XP
Int J Biol Markers; 2013 Sep; 28(3):259-66. PubMed ID: 23709347
[TBL] [Abstract] [Full Text] [Related]
11. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.
Tan S; Sun C; Wei X; Li Y; Wu Y; Yan Z; Feng F; Wang J; Wu Y
Exp Lung Res; 2013; 39(4-5):182-90. PubMed ID: 23614702
[TBL] [Abstract] [Full Text] [Related]
12. Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis.
Antczak A; Migdalska-Sęk M; Pastuszak-Lewandoska D; Czarnecka K; Nawrot E; Domańska D; Kordiak J; Górski P; Brzeziańska E
Med Oncol; 2013 Jun; 30(2):532. PubMed ID: 23504373
[TBL] [Abstract] [Full Text] [Related]
13. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
[TBL] [Abstract] [Full Text] [Related]
14. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L
Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913
[TBL] [Abstract] [Full Text] [Related]
15. EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.
Field JK; Liloglou T; Niaz A; Bryan J; Gosney JR; Giles T; Brambilla C; Brambilla E; Vesin A; Timsit JF; Hainaut P; Martinet Y; Vignaud JM; Thunnissen FB; Prinsen C; Snijders PJ; Smit EF; Sozzi G; Roz L; Risch A; Becker HD; Elborn JS; Magee ND; Montuenga LM; Pajares MJ; Lozano MD; O'Byrne KJ; Harrison DJ; Niklinski J; Cassidy A;
Eur Respir J; 2009 Dec; 34(6):1477-86. PubMed ID: 19948914
[TBL] [Abstract] [Full Text] [Related]
16. Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer.
Jiang F; Todd NW; Qiu Q; Liu Z; Katz RL; Stass SA
Lung Cancer; 2009 Oct; 66(1):58-63. PubMed ID: 19181417
[TBL] [Abstract] [Full Text] [Related]
17. Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis.
Qiu Q; Todd NW; Li R; Peng H; Liu Z; Yfantis HG; Katz RL; Stass SA; Jiang F
Cancer; 2008 Aug; 114(4):275-83. PubMed ID: 18484646
[TBL] [Abstract] [Full Text] [Related]
18. fhit protein expression in lung cancer studied by high-throughput tissue microarray.
Feng X; Li L; Gao Y; Zhang J; Ying J; Xiao T; Gao J; Liu X; Sun Y; Cheng S
Bull Cancer; 2007 Mar; 94(3):E8-11. PubMed ID: 17371765
[TBL] [Abstract] [Full Text] [Related]
19. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
[TBL] [Abstract] [Full Text] [Related]
20. Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?
de Fraipont F; Moro-Sibilot D; Michelland S; Brambilla E; Brambilla C; Favrot MC
Lung Cancer; 2005 Nov; 50(2):199-209. PubMed ID: 16043258
[TBL] [Abstract] [Full Text] [Related]
[Next]
